Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials (Q30686073)

26 June 2017

1 reference

1 reference

1 reference

title

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials (English)

1 reference

26 June 2017

0 references

0 references

1 reference

L A Stewart

1

1 reference

PubMed ID

11937180

26 June 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

26 June 2017

1 reference

26 June 2017

359

1 reference

26 June 2017

1011-1018

1 reference

26 June 2017

9311

1 reference

A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party

26 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908091-1

7 January 2021

An overview of published results from randomized studies of nitrosoureas in primary high grade malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908091-1

7 January 2021

Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908091-1

7 January 2021

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908091-1

7 January 2021

The existence of publication bias and risk factors for its occurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908091-1

7 January 2021

Meta-analysis of the literature or of individual patient data: is there a difference?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908091-1

7 January 2021

Systematic reviews using individual patient data: a map for the minefields?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908091-1

7 January 2021

Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908091-1

7 January 2021

Identifying relevant studies for systematic reviews

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908091-1

7 January 2021

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908091-1

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908091-1

7 January 2021

Long-term survival and recurrence-free interval in combined surgical, radio- and chemotherapy of malignant brain gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908091-1

7 January 2021

CCNU-chemotherapy of hemispheric supratentorial glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908091-1

7 January 2021

Adjuvant nitrosourea therapy for glioblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908091-1

7 January 2021

Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Stud

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908091-1

7 January 2021

Combined modality treatment of operated astrocytomas grade 3 and 4. A prospective and randomized study of misonidazole and radiotherapy with two different radiation schedules and subsequent CCNU chemotherapy. Stage II of a prospective multicenter tr

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908091-1

7 January 2021

Effect of CCNU on survival rate of objective remission and duration of free interval in patients with malignant brain glioma—Final evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908091-1

7 January 2021

Effects of ACNU and radiotherapy on malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908091-1

7 January 2021

Controlled study of CCNU and radiation therapy in malignant astrocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908091-1

7 January 2021

Dianhydrogalactitol and radiation therapy. Treatment of supratentorial glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908091-1

7 January 2021

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908091-1

7 January 2021

Radiotherapy and CCNU in the treatment of high-grade supratentorial astrocytomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908091-1

7 January 2021

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908091-1

7 January 2021

Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908091-1

7 January 2021

Evaluation of CCNU, VM-26 plus CCNU, and procarbazine in supratentorial brain gliomas. Final evaluation of a randomized study. European Organization for Research on Treatment of Cancer (EORTC) Brain Tumor Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908091-1

7 January 2021

Combined radiotherapy and chemotherapy with dibromodulcitol and CCNU in the postoperative treatment of malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908091-1

7 January 2021

Postoperative radiotherapy and radiotherapy combined with CCNU chemotherapy for treatment of brain gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908091-1

7 January 2021

Adjuvant therapy with dibromodulcitol and BCNU increases survival of adults with malignant gliomas. EORTC Brain Tumor Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908091-1

7 January 2021

10.1016/S0140-6736(02)08091-1

Identifiers

DOI

1 reference

26 June 2017

1 reference

PubMed ID

11937180